CLINICAL_TRIALS
trial_result
· 2025-02-25
Clinical Trial Update: Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria [Phase 3]
Summary
Phase 3 trial evaluating azithromycin for severe acute malnutrition in CMAM, Nigeria. The study was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Severe Acute Malnutrition | Phase 3 | Status: TERMINATED | Results posted: 2025-02-25